Jump to the top of the page

Showing 590 – 600 of 1158 results

  • Hepberger Joins William Blair Healthcare Investment Banking

    William Blair today announced the hiring of Rainer Hepberger as a managing director on the firm's healthcare investment banking team.

  • Things Are Improving for Lower Income Consumers

    In this Economics Weekly we take a look at the consumer, what’s happened with regard to the wealth inequality gap, and why some of the more recent economic data actually sheds a ray of hope that solid progress is being made in addressing this issue.

  • TPG and EIS Transaction

    William Blair acted as financial advisor to TPG Capital in connection with its pending growth investment in EIS.

  • Vestar Capital Partners and PetHonesty Transaction

    William Blair acted as exclusive financial advisor to Vestar Capital Partners in connection with the majority investment in PetHonesty, a leader in premium pet supplements.

  • Sparta Systems and Honeywell

    William Blair acted as financial advisor to Sparta Systems, Inc. (Sparta), a portfolio company of New Mountain Capital, in connection with its pending sale to Honeywell (NYSE: HON).

  • Japan Stewardship Code

    William Blair is a signatory to the Japan Stewardship Code.

  • David Brown

    View biography for David Brown, partner, wealth advisor.

  • Updating FDA Approval Analysis for 2024 Data

    Discover the latest insights in pharmaceutical outsourcing and services with our comprehensive analysis of FDA approvals for 2024. This report delves into the trends and key conclusions from a decade of data, highlighting the significant uptick in outsourcing penetration and the robust growth in biotech funding.

  • Hypergene and Thoma Bravo Transaction

    William Blair acted as the exclusive financial advisor to Hypergene, a portfolio company of Monterro, on its pending sale to Thoma Bravo for an undisclosed amount.

  • Accelerant transaction

    William Blair acted as a joint bookrunner on a $832 million initial public offering for Accelerant Holdings (NYSE: ARX), a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures